The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2017. The average startup value when the investment from Joyful Ascent is more than 1 billion dollars. The common things for fund are deals in the range of more than 100 millions dollars.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are ShenZhen GTJA Investment Group, Shanghai Fosun Pharmaceutical (Group) Co.,Ltd, Green Tomato. In the next rounds fund is usually obtained by New China Capital Management, Loyal Valley Capital, Green Tomato.
Among the most popular portfolio startups of the fund, we may highlight Shanghai Henlius. Among the most successful fund investment fields, there are Pharmaceutical, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
| Fund Name | Location |
| Black Powder | - |
| Daum-Kakao Youth Growth Fund | - |
| FinStart Nordic | - |
| Health Evolution Partners | California, San Francisco, United States |
| Humania Assurance | Canada, Quebec, Saint-hyacinthe |
| Insight Investment | England, London, United Kingdom |
| Investing Profit Wisely | - |
| NDCapital | California, Los Angeles, United States |
| Vives Fund | Belgium, Louvain-la-neuve, Vlaams-Brabant |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Shanghai Henlius Biotech | $190M | 22 Dec 2017 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Shanghai Henlius Biotech | $190M | 22 Dec 2017 | Shanghai, China |
